cyanocobalamin co-57
Trade name: rubratope-57
Small moleculeapprovedImaging agent
Approved
Jun 21, 1968
Clinical trial activity
0 trials · 0 clinical orgs · 3 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1960s
- Jun 21, 1968
Earliest FDA Approval
- Jun 21, 1968
Mallinckrodt — Marketing Organization
- Jun 21, 1968
Mallinckrodt — NDA Secondary Org
1970s
- Dec 21, 1970
Bracco — First NDA Organization
- Dec 21, 1970
Bracco — NDA Secondary Org
- Dec 21, 1970
Bracco — NDA Organization
- Jun 10, 1974
General Electric — Marketing Organization
- Jun 10, 1974
General Electric — NDA Secondary Org
Indications
Approved for
Mechanism of action
- Methionine synthaseBINDING AGENT
MTR binding agent
Combination products
dicopac
Approval history
- approvedJun 21, 1968
Chemistry & pharmacology
- Mol. weight
- 1354.4 g/mol
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Oral
- Availability
- Discontinued
- Imaging
- 57-Cobalt
Oral
Yes
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2096655 ↗
Also known as
- cobalt (57co) cyanocobalamine
- cobalt (57co) cyanocobalamine
- cyanocobalamin (57co)
- cyanocobalamin (57co)
- cyanocobalamin co 57
- cyanocobalamin co 57
- cyanocobalamin co-57
- cyanocobalamin co-57
- cyanocobalamin co-57
- cyanocobalamin co-57
- cyanocobalamin co 57 schilling test kit
- cyanocobalamin; cyanocobalamin co-57; intrinsic factor
- racobalamin-57
- rubratope-57
- rubratope-57
Organizations
Marketing (6)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Bracco | For profit | NDA2 | Dec 21, 1970 |
| Bracco | For profit | NDA | Dec 21, 1970 |
| General Electric | For profit | MKTG | Jun 10, 1974 |
| General Electric | For profit | NDA2 | Jun 10, 1974 |
| Mallinckrodt | For profit | MKTG | Jun 21, 1968 |
| Mallinckrodt | For profit | NDA2 | Jun 21, 1968 |